Latest news with #IAPB
Globe and Mail
3 days ago
- Business
- Globe and Mail
Global Ophthalmic Implants Market Revenue to Reach USD 8.14 billion by 2030 – Exclusive Research by Focus Reports
"Global Ophthalmic Implants Market Revenue to Reach USD 8.14 billion by 2030 - Exclusive Research by Focus Reports" Industry Analysis Report, Regional Outlook, Growth Potential, Price Trends, Competitive Market Share & Forecast 2025–2030. According to Focus Report's latest research report, the global ophthalmic implants market is growing at a CAGR of 7.48% during 2021-2030. Looking for More Information? Click: Report Scope: Market Size (2030): USD 8.14 Billion Market Size (2024): USD 5.28 Billion CAGR (2024-2030): 7.48% Historic Year: 2021-2023 Base Year: 2024 Forecast Year: 2025-2030 Largest Region (2024): North America Fastest-Growing Region: Asia Pacific Market Segmentation: Product, Application, End-Users, and Geography Geographic Analysis: North America, Europe, APAC, Latin America, and the Middle East & Africa Market Overview The global ophthalmic implants market is evolving rapidly, driven by the increasing burden of eye diseases, a growing ageing population, and rising healthcare expenditure dedicated to vision care. Eye health continues to be a critical global concern, with leading organizations such as the World Health Organization (WHO), the International Agency for the Prevention of Blindness (IAPB), and the American Academy of Ophthalmology, along with numerous regional and national health authorities, playing an active role in promoting eye care awareness and access to surgical interventions. The COVID-19 pandemic significantly disrupted the ophthalmology landscape, resulting in widespread delays and cancellations of elective eye surgeries and consultations. This disruption led to a notable slowdown in the ophthalmic implants market between 2019 and 2020, with a substantial decline in surgical volumes and overall market revenues. However, easing restrictions in 2021 led to a surge in postponed procedures, boosting demand for ophthalmic implants. After a slight dip in 2022 as backlogs cleared, the market has stabilized since 2023 and is expected to maintain consistent growth supported by ongoing innovations and rising patient awareness. Growing Adoption of Synthetic Corneal Implants Expands Treatment Options for High-Risk Patients The growing use of synthetic corneal implants is bringing new hope to patients suffering from corneal blindness, especially those who cannot undergo traditional corneal transplants. While donor cornea transplants work well for many, they often fail in patients with conditions like chronic inflammation, glaucoma, herpes infections, or excessive blood vessel growth in the cornea. In addition, the global demand for donor corneas far exceeds supply, particularly in developing countries. Synthetic corneal implants, known as keratoprostheses, offer an effective alternative. According to the Cornea Research Foundation of America (2025), these fully artificial implants are now widely available and are helping restore vision in patients who are not suitable for human donor transplants. With an estimated 11 million people worldwide affected by bilateral corneal blindness (2022), this advancement is making treatment more accessible, reducing wait times, and improving outcomes for those most in need. By offering a reliable solution where traditional methods fall short, synthetic implants are enhancing care and quality of life for patients around the world. Rising Adoption of Advanced Ocular Devices Opens New Horizons in Eye Care Market The eye implant market is witnessing significant momentum, driven by the rising acceptance of advanced ocular technologies such as artificial eyes and glaucoma management devices. This growing adoption is being further supported by a surge in regulatory approvals, enabling leading manufacturers to expand their product portfolios and capitalize on new revenue streams. Ongoing investments in R&D are paving the way for next-generation eye care solutions, with cutting-edge ophthalmic diagnostics accelerating clinical acceptance and market penetration. Increased digital accessibility has also played a crucial role in patient education, empowering individuals to explore innovative treatment options and thereby boosting demand. One notable advancement gaining traction is the artificial corneal implant, which has emerged as a crucial alternative for patients unsuitable for human donor transplants. As highlighted by the Cornea Research Foundation of America (2023), while over 11 million people globally suffer from corneal blindness, only 100,000 receive donor-based implants, underscoring a critical gap and reinforcing the need for synthetic alternatives. The European Blind Union (2022) reports that nearly 30 million people in Europe are affected by visual impairments, driving the need for more frequent and sophisticated corneal procedures. With an aging population and rising expectations for high-quality eye care, the adoption of advanced ocular implants is expected to accelerate in the years ahead. Recent Vendor Activities In 2024, Alimera Sciences was acquired by ANI Pharmaceuticals to expand its footprint into the ophthalmology sector. This transaction is valued at around $381 million. Alimera Sciences was offered 2 ophthalmic implants that treat posterior eye diseases. In 2024, Johnson & Johnson Medtech- one of the global companies in eye health launched TECNIS PureSee (Intraocular Lens) to correct refractive presbyopia in Europe and the Middle East and Africa (EMEA). In 2024, Occular Therapeutix, a biopharmaceutical company, announced that the first patients had been enrolled in the phase 3 SOL-R clinical studies evaluating repeat dosing of the AXPAXLI implant for the treatment of a patient with wet AMD. Strategic Innovations and Collaborations Drive Expansion in Ophthalmic Implants Market In recent years, the global ophthalmic implants industry has experienced dynamic strategic activities, including mergers, acquisitions, and partnerships, aimed at expanding global footprints and accelerating product innovation. Leading companies such as Alcon, ZEISS Group, Bausch + Lomb, and Johnson & Johnson continue to dominate the market, offering advanced ophthalmic implant solutions that not only fulfill consumer needs but also adhere to stringent regulatory standards. These key players are enhancing product efficiency and solidifying their market positions through robust brand presence and extensive geographic reach worldwide. The competitive landscape has intensified as vendors increasingly deploy strategies like new product launches, strategic mergers and acquisitions, and the integration of cutting-edge technologies and materials into their offerings. A notable example includes Science Corporation's acquisition of Pixium's PRIMA Retinal Implants, marking a significant step in their commitment to vision restoration. While this innovative retinal implant is not yet commercially available, promising preliminary clinical trial results highlight the potential of emerging technologies to revolutionize ocular care and expand market opportunities. Key Vendors Alcon Carl Zeiss Bausch + Lomb Johnson & Johnson Other Prominent Vendors AJL Ophthalmic BVI Care Group CorNeat Vision Devine Meditech EyeD Pharma Ani Pharmaceuticals Eyedeal Medical Technology Company Limited Müller Söhne Gulden Ophthalmics Glaukos HumanOptics Hoya Corporation LambdaVision Labtician Ophthalmics MORCHER iSTAR Medical Ophtec Omni Lens Rayner Intraocular Lenses Limited SMR OPHTHALMIC Ocular Therapeutix F. Hoffmann-La Roche Market Segmentation & Forecast Product Intraocular Lenses Glaucoma Implants Corneal Implants Others Application Cataract Surgery Glaucoma Surgery Other Applications End-Users Hospitals Ophthalmic Clinics Other End-User Geography North America US Canada Europe Germany UK France Italy Spain APAC China Japan India Australia South Korea Latin America Brazil Mexico Argentina Middle East & Africa Turkey Saudi Arabia South Africa Other Related Reports that Might be of Your Business Requirement Global Contact Lenses Market - Focused Insights 2024-2029 Global Disposable Contact Lenses Market - Focused Insights 2024-2029 What Key Findings Will Our Research Analysis Reveal? How big is the global ophthalmic implants market? What are the factors driving the global ophthalmic implants market growth? Which product type will dominate the global ophthalmic implants market growth? Which region will have the highest growth in the global ophthalmic implants market? Who are the major players in the global ophthalmic implants market? What is the growth rate of the global ophthalmic implants market? Why Arizton? 100% Customer Satisfaction 24x7 availability – we are always there when you need us 200+ Fortune 500 Companies trust Arizton's report 80% of our reports are exclusive and first in the industry 100% more data and analysis 1500+ reports published till date Post-Purchase Benefit 1hr of free analyst discussion 10% off on customization About Us: Arizton Advisory and Intelligence is an innovative and quality-driven firm that offers cutting-edge research solutions to clients worldwide. We excel in providing comprehensive market intelligence reports and advisory and consulting services. We offer comprehensive market research reports on consumer goods & retail technology, automotive and mobility, smart tech, healthcare, life sciences, industrial machinery, chemicals, materials, I.T. and media, logistics, and packaging. These reports contain detailed industry analysis, market size, share, growth drivers, and trend forecasts. Arizton comprises a team of exuberant and well-experienced analysts who have mastered generating incisive reports. Our specialist analysts possess exemplary skills in market research. We train our team in advanced research practices, techniques, and ethics to outperform in fabricating impregnable research reports.
The Sun
26-04-2025
- Health
- The Sun
Public-private collaboration crucial for accessible eye care
KUALA LUMPUR: The responsibility of safeguarding Malaysia's eye care is a shared endeavour, said Bandar Tun Razak member of parliament Datuk Seri Dr Wan Azizah Wan Ismail. The wife of the Prime Minister said both public and private hospitals play a crucial role as caretakers of eye health, ensuring that quality eye care is accessible to all. 'This collective effort strengthens our ability to provide world-class ophthalmology services, bridging gaps in accessibility and bringing vision care closer to communities in need,' she said when officiating the Malaysian Ophthalmology Scientific Congress (MOSC) 2025 here today. Noting that Malaysia has achieved a significant milestone in ophthalmology practice, Wan Azizah said the National Eye Survey III, conducted in 2023, reported a dramatic reduction in the prevalence of blindness in earmarked regions across the country. She said the survey recorded a decrease from 1.6 per cent to 0.8 per cent in the eastern regions, and from 2.1 per cent to 0.6 per cent in Sarawak, reflecting the nation's progress in enhancing eye care services. 'It is truly impressive to see progress in achievements and advancements in this field spearheaded by the young of today, a testament to the power of innovation, determination and community-focused care,' she said. The former deputy prime minister said the National Eye Database (NED), established in 2002, has been instrumental in this journey, empowering ophthalmologists to make evidence-based decisions that continually improve patient outcomes. Wan Azizah said the data-driven approach earned Malaysia the honour of hosting the World Health Organisation/ International Agency for the Prevention of Blindness (IAPB) meeting on cataract surgery outcomes in 2018, describing it as a proud moment that highlighted the country's leadership in global eye care standards. On the MOSC, she said the three-day congress, themed 'United We Stand: One Vision for Malaysia,' which began yesterday, brings together a distinguished assembly of professionals from both public and private healthcare sectors to share knowledge and discuss strategies to improve the future of eye care in Malaysia. At the event, Wan Azizah was presented with the Lifetime Achievement in Ophthalmology 2025 Award in recognition of her outstanding contributions to the field, having previously served as an ophthalmologist from 1978 to 1993.
The Sun
26-04-2025
- Health
- The Sun
Public-private collaboration crucial to ensuring quality, accessible eye care
KUALA LUMPUR: The responsibility of safeguarding Malaysia's eye care is a shared endeavour, said Bandar Tun Razak member of parliament Datuk Seri Dr Wan Azizah Wan Ismail. The wife of the Prime Minister said both public and private hospitals play a crucial role as caretakers of eye health, ensuring that quality eye care is accessible to all. 'This collective effort strengthens our ability to provide world-class ophthalmology services, bridging gaps in accessibility and bringing vision care closer to communities in need,' she said when officiating the Malaysian Ophthalmology Scientific Congress (MOSC) 2025 here today. Noting that Malaysia has achieved a significant milestone in ophthalmology practice, Wan Azizah said the National Eye Survey III, conducted in 2023, reported a dramatic reduction in the prevalence of blindness in earmarked regions across the country. She said the survey recorded a decrease from 1.6 per cent to 0.8 per cent in the eastern regions, and from 2.1 per cent to 0.6 per cent in Sarawak, reflecting the nation's progress in enhancing eye care services. 'It is truly impressive to see progress in achievements and advancements in this field spearheaded by the young of today, a testament to the power of innovation, determination and community-focused care,' she said. The former deputy prime minister said the National Eye Database (NED), established in 2002, has been instrumental in this journey, empowering ophthalmologists to make evidence-based decisions that continually improve patient outcomes. Wan Azizah said the data-driven approach earned Malaysia the honour of hosting the World Health Organisation/ International Agency for the Prevention of Blindness (IAPB) meeting on cataract surgery outcomes in 2018, describing it as a proud moment that highlighted the country's leadership in global eye care standards. On the MOSC, she said the three-day congress, themed 'United We Stand: One Vision for Malaysia,' which began yesterday, brings together a distinguished assembly of professionals from both public and private healthcare sectors to share knowledge and discuss strategies to improve the future of eye care in Malaysia. At the event, Wan Azizah was presented with the Lifetime Achievement in Ophthalmology 2025 Award in recognition of her outstanding contributions to the field, having previously served as an ophthalmologist from 1978 to 1993.
Malay Mail
26-04-2025
- Health
- Malay Mail
Strengthen public-private ties to advance eye health, Wan Azizah urges
KUALA LUMPUR, April 26 — The responsibility of safeguarding Malaysia's eye care is a shared endeavour, said Bandar Tun Razak MP Datuk Seri Dr Wan Azizah Wan Ismail. The wife of the Prime Minister said both public and private hospitals play a crucial role as caretakers of eye health, ensuring that quality eye care is accessible to all. 'This collective effort strengthens our ability to provide world-class ophthalmology services, bridging gaps in accessibility and bringing vision care closer to communities in need,' she said when officiating the Malaysian Ophthalmology Scientific Congress (MOSC) 2025 here today. Noting that Malaysia has achieved a significant milestone in ophthalmology practice, Wan Azizah said the National Eye Survey III, conducted in 2023, reported a dramatic reduction in the prevalence of blindness in earmarked regions across the country. She said the survey recorded a decrease from 1.6 per cent to 0.8 per cent in the eastern regions, and from 2.1 per cent to 0.6 per cent in Sarawak, reflecting the nation's progress in enhancing eye care services. 'It is truly impressive to see progress in achievements and advancements in this field spearheaded by the young of today, a testament to the power of innovation, determination and community-focused care,' she said. The former deputy prime minister said the National Eye Database (NED), established in 2002, has been instrumental in this journey, empowering ophthalmologists to make evidence-based decisions that continually improve patient outcomes. Wan Azizah said the data-driven approach earned Malaysia the honour of hosting the World Health Organisation/International Agency for the Prevention of Blindness (IAPB) meeting on cataract surgery outcomes in 2018, describing it as a proud moment that highlighted the country's leadership in global eye care standards. On the MOSC, she said the three-day congress, themed 'United we stand: One vision for Malaysia,' which began yesterday, brings together a distinguished assembly of professionals from both public and private healthcare sectors to share knowledge and discuss strategies to improve the future of eye care in Malaysia. At the event, Wan Azizah was presented with the Lifetime Achievement in Ophthalmology 2025 Award in recognition of her outstanding contributions to the field, having previously served as an ophthalmologist from 1978 to 1993. — Bernama
